Are hospitals actually using AI today?

In our healthcare AI market deck, you will find everything you need to understand the market
SUMMARY
Hospitals are already using AI today, at scale, but mostly as supervised infrastructure rather than as an autonomous medical decision-maker.
The dominant form of hospital AI is narrow and practical. It drafts notes, reviews scans, calculates risk, suggests codes, sorts claims and moves urgent work to the front of a queue.
Adoption is broad but highly unequal. Predictive AI is already present in most American acute-care hospitals, while large health systems remain far ahead of small, rural and independent hospitals.
“Using AI” still covers very different realities. A six-week pilot with ten doctors and a system used daily by thousands of clinicians both count as adoption, but they do not prove the same thing.
Medical imaging is the most mature clinical market because scans are digital, tasks can be tightly defined and specialists can review the output. Even there, AI is mainly a second reader and workflow tool.
AI scribes are the fastest-moving generative application. Their gains are real but modest: roughly a minute saved per appointment in a large Providence study, with usage still uneven among eligible clinicians.
The strongest evidence of better patient outcomes comes from urgent problems with an established treatment. Stroke imaging and well-integrated sepsis alerts can matter because a faster response changes what clinicians are able to do.
Administrative AI is spreading faster than autonomous clinical AI. Billing, scheduling, coding and claims offer clearer returns, larger volumes and errors that humans can usually catch before harm occurs.
Governance has improved, but it is patchy. Large systems are far more likely to test accuracy, assess bias and monitor models after launch than independent hospitals with thinner technical teams.
AI is changing jobs by removing pieces of work, not by replacing whole clinical professions. Notes, measurements, scheduling and first-pass reviews are being automated while humans keep responsibility for consequential decisions.
The hype begins when these supervised tools are described as an AI doctor or an autonomous hospital. The real transformation is less cinematic and more important: algorithms are quietly changing the order, speed and cost of everyday hospital work.

This market map, featured in our healthcare AI market deck, highlights top companies and startups in the healthcare AI market
Hospitals are already using AI for real work, and the evidence now goes far beyond a few famous medical centers. Algorithms help write notes, review scans, flag deteriorating patients, code claims, schedule appointments and sort administrative queues every day.
The confusion comes from the huge gap between that reality and the popular image of hospital AI. Most hospitals have several narrow tools, each handling one small part of the workflow. Very few let AI make major clinical decisions on its own.
We also need to separate three different questions. Has a hospital bought or tested an AI tool? Are employees regularly using it? Has it made care better, faster or cheaper? Hospitals can answer yes to the first question while still struggling with the other two.
The clearest national adoption data currently come from the United States. England, meanwhile, offers one of the strongest examples of a health service rolling out clinical AI across an entire country. Taken together, the evidence shows what hospitals are actually doing today.
What counts as hospital AI use today?
Hospital AI use today begins when an algorithm touches real care or real hospital work rather than remaining in a research paper, sales demo or unused software licence.
That includes older predictive systems as well as newer generative AI. A model that estimates a patient’s sepsis risk counts. So does software that identifies a possible brain bleed on a scan, drafts a medical note or suggests a billing code.
A small pilot also counts as use, although it tells us much less than a hospital-wide rollout. Ten doctors testing an AI scribe for six weeks and 2,000 doctors using it every day should never be placed in the same category.
For this analysis, we treat AI as genuinely deployed when it works on real patients, records, scans, claims or hospital operations. We then ask how widely it is used, whether a human checks its output and whether the hospital has measured any benefit.
That definition also explains why many patients have already encountered hospital AI without knowing it. The software may have changed the order in which their scan was reviewed, calculated a risk score in the background or helped prepare a document that still carried a clinician’s signature.
Is hospital AI common now, or only used by elite medical centers?
Hospital AI is already common in the United States, especially inside large hospitals and multihospital systems.
The latest broad federal analysis examined the American Hospital Association’s technology survey. It found that 71% of non-federal acute-care hospitals were using predictive AI connected to their electronic health record, up from 66% one year earlier.
That figure came from more than 2,000 hospitals, so it carries more weight than a collection of hospital announcements. It covers models used for inpatient risk, outpatient follow-up, treatment recommendations, billing and scheduling.
The data do lag behind the market because national surveys take time to collect and publish. Even so, they show that predictive AI had already reached most hospitals before the latest wave of generative AI deployments was fully captured.
Size changes the picture dramatically. AI use reached 96% among large hospitals but only 59% among small ones. Hospitals belonging to a larger system were more than twice as likely to use it as independent hospitals.
| Hospital group | Using predictive AI | What it tells us |
|---|---|---|
| Large hospitals | 96% | AI is close to standard infrastructure |
| Small hospitals | 59% | Use is common but far from universal |
| Multihospital system members | 86% | Shared technology teams speed up adoption |
| Independent hospitals | 37% | Many standalone hospitals remain behind |
| Urban hospitals | 81% | Urban systems have stronger technical capacity |
| Rural hospitals | 56% | Rural adoption still trails badly |
If you want more recent data on this point, please see our latest healthcare AI market report.

As this chart shows, and as featured in our healthcare AI market deck, search interest in healthcare AI has grown rapidly
Are hospitals running AI in production or still testing it?
Many hospitals have moved beyond pilots, although full deployment remains concentrated in a few mature uses.
A detailed study published in the Journal of the American Medical Informatics Association surveyed 43 large nonprofit health systems about 37 AI applications. The researchers separated development, pilots, limited deployment and full deployment. That is far more useful than a simple yes-or-no adoption figure.
Imaging and sepsis tools were the furthest along. Forty percent of systems had fully deployed imaging AI, and another 50% used it in limited areas. Almost half had fully deployed AI for early sepsis detection.
Generative AI was moving quickly but had less depth. Every system had started developing, piloting or deploying ambient documentation, yet only 14% had rolled it out fully.
That is the normal state of hospital AI today. A hospital may have used radiology algorithms for years, run a sepsis model across several wards and still be testing generative AI with a few dozen doctors.
| AI use case | No activity | Developing or piloting | Limited deployment | Full deployment |
|---|---|---|---|---|
| Imaging and radiology | 5% | 5% | 50% | 40% |
| Early sepsis detection | 12% | 21% | 19% | 48% |
| Clinical deterioration risk | 9% | 35% | 19% | 37% |
| Ambient clinical notes | 0% | 40% | 47% | 14% |
| Patient-message automation | 7% | 42% | 37% | 14% |
| Medical coding | 17% | 38% | 21% | 24% |
Where is hospital AI doing the most work today?
Hospital AI currently does most of its work in notes, scans, risk scores, claims and scheduling.
These jobs have several things in common. They happen thousands of times, the information is already digital and an employee can check the result before anything serious happens.
The latest American Medical Association survey found that 81% of physicians were using AI professionally, more than double the share reported three years earlier. The average physician respondent was also using 2.3 AI applications, up from 1.1.
The breakdown matters more than the headline. Thirty-nine percent used AI to summarize medical research or standards of care. Thirty percent used it for discharge instructions, care plans or progress notes. Twenty-eight percent used it for documentation and billing, while 28% used chart summaries.
Only 17% reported using AI for assistive diagnosis. Hospitals are clearly more comfortable with writing, searching, sorting and summarizing than with high-stakes medical judgment.
Hospital AI has grown through thousands of small workflow decisions. It helps someone find information faster, prepares a first draft or pushes urgent work higher in a queue. Those actions sound modest individually, but they add up across millions of visits, scans and claims.

This chart, featured in our healthcare AI market deck, shows annual VC investment in healthcare AI startups
Is medical imaging the first mature hospital AI market?
Medical imaging is currently the clearest mature clinical AI market.
The FDA’s updated list through its latest complete reporting period contained 1,524 AI-enabled medical devices. Around 1,164, or 76%, belonged to radiology. Medical imaging’s real share is slightly higher because some image-based tools appear under cardiology, neurology and other specialties.
Radiology reached this position for practical reasons. Hospitals have stored scans digitally for decades, imaging tasks can be narrowly defined and developers can compare an algorithm’s output with a known diagnosis.
Most products still perform one focused job. They may flag a suspected stroke, measure a tumour, highlight a possible pulmonary embolism or move an urgent scan to the top of a radiologist’s list.
Hospital use follows that supply. Ninety percent of the large health systems surveyed by JAMIA had deployed imaging AI somewhere in their organization.
Yet only 19% rated their clinical-diagnosis AI efforts as highly successful. Hospitals have plenty of imaging tools available, but integrating them smoothly into daily work remains difficult. Some produce too many alerts, save little time or perform differently on local patients and scanners.
England offers one of the strongest counterexamples. Its health service has rolled out AI imaging support across all stroke units that regularly admit patients. Doctors still make the treatment decision, while the software quickly analyses scans and helps hospitals transfer suitable patients to specialist centers.
Imaging AI has reached genuine clinical scale. Its mature form today is a fast second reader and workflow assistant rather than an autonomous radiologist.
If you want more recent data on this point, please see our latest healthcare AI market report.
Are AI scribes becoming normal in hospitals?
AI scribes are becoming normal hospital software faster than any other generative AI application.
Ambient systems listen to a consultation and prepare a draft note. The doctor reviews, edits and signs it. That simple workflow targets one of clinicians’ most disliked tasks without handing the software control over treatment.
Every health system in the JAMIA survey had begun working on ambient notes. Sixty-one percent had already moved into limited or full deployment, an unusually fast shift for hospital technology.
The newest large-scale evidence gives us a realistic measure of the benefit. Providence studied 1,547 physicians and advanced-practice clinicians who actively used its ambient system. Median note time fell from 7.1 to 6.1 minutes per appointment, and after-hours documentation gradually declined.
And yes, one minute sounds small until it is repeated across 20 daily appointments. That becomes roughly 20 minutes a day and more than 80 hours over a working year.
Adoption within Providence still remained uneven. Active users represented about 8% of eligible clinicians over the full study period, although monthly use climbed as high as 28.8%. Providing access clearly does not guarantee that every clinician will keep using the tool.
A separate UCSF study examined more than 1.2 million appointments. Access to AI scribes was associated with a 5.8% increase in weekly billed work and a 2.8% increase in visits, without a rise in rejected claims.
These tools also cost money, typically around $200 to $600 per clinician each month according to a recent JAMA review. Hospitals therefore need the saved time, extra capacity or improved staff retention to outweigh the subscription and implementation costs.
AI scribes have passed the novelty stage. The harder question now is whether enough clinicians find them accurate and useful to justify a broad rollout.

This chart, featured in our healthcare AI market deck, looks at Tempus AI’s strategy in healthcare AI
Are hospitals letting AI diagnose patients?
Hospital AI currently supports diagnosis while licensed clinicians keep the final call.
An imaging algorithm can spot a suspicious area or prioritize a scan. A cardiac model can identify an abnormal pattern. A pathology tool can mark tissue that deserves closer inspection. In each case, the specialist remains responsible for the complete interpretation.
The AMA’s latest physician survey shows how limited diagnostic use still is. Eighty-one percent of physicians reported professional AI use, but only 17% used it for assistive diagnosis. Documentation, research summaries and chart reviews were much more common.
The FDA device count can also be misleading. More than 1,500 authorized AI devices sounds like a large army of automated doctors. In practice, most are narrow products built for a defined input, patient group and medical task.
Hospitals also show less confidence in diagnostic AI than their adoption numbers suggest. Ninety percent of the large systems in the JAMIA study had imaging AI somewhere, while only 19% described their diagnostic AI work as highly successful.
We found plenty of evidence that AI changes how clinicians review cases. We found very little evidence of hospitals routinely allowing a general AI system to diagnose patients without professional oversight.
For now, diagnostic AI works best when it gives a specialist another piece of evidence, catches a possible oversight or saves time on a repetitive measurement.
Is predictive AI changing decisions on hospital wards?
Predictive AI already changes which hospital patients receive attention first.
These models estimate the chance of sepsis, deterioration, readmission, falls or other problems. A high score can prompt a nurse review, a rapid-response assessment or closer monitoring.
The federal hospital survey found that inpatient risk prediction was the most common predictive AI use. Among the large health systems studied separately, 56% had deployed deterioration-risk models and 52% had deployed tools for unplanned readmission risk.
The useful output is often a change in priority. A patient who looks stable may move higher on a worklist because several small changes in laboratory results and vital signs form a worrying pattern.
Accuracy alone does not tell us whether the system works. The alert has to reach the right person early enough, and that employee needs a clear action to take.
Hospitals have learned this the hard way. Too many weak alerts create alarm fatigue, while a model that identifies high-risk patients without offering a workable response produces little value.
Predictive AI works best inside a prepared clinical process. The model finds the pattern, the hospital decides who receives the alert, and staff know what should happen next.

This chart, featured in our healthcare AI market deck, shows annual funding in healthcare AI startups
Does sepsis AI actually save lives?
Sepsis AI can save lives when hospitals pair a reliable model with a fast clinical response.
The strongest example is the Targeted Real-time Early Warning System, known as TREWS. Researchers followed its use across five hospitals and found that patients whose alerts were confirmed by clinicians within three hours had an adjusted mortality rate 3.3 percentage points lower. That was an 18.7% relative reduction.
A second system, COMPOSER, was deployed in two University of California San Diego emergency departments. The study covered 6,217 patients with sepsis. Deployment was associated with a 1.9-percentage-point reduction in in-hospital mortality and a five-point improvement in compliance with the recommended sepsis-treatment bundle.
These were not just good prediction scores. In both cases, the alert was connected to a workflow that could get patients treated sooner.
Poorly performing sepsis models have produced the opposite lesson. An independent Michigan Medicine evaluation of Epic’s widely used model found that it missed roughly two-thirds of sepsis cases under the researchers’ testing conditions and generated many false alerts.
Hospitals cannot treat every sepsis product as interchangeable. The training data, warning threshold, local patient population and clinical response all shape the outcome.
That explains why 67% of the large systems surveyed had deployed sepsis AI, while only 38% described their broader clinical risk-stratification work as highly successful. Sepsis AI has crossed the threshold into useful medicine, but only some deployments are getting the full benefit.
If you want more recent data on this point, please see our latest healthcare AI market report.
Are hospitals using generative AI beyond note-taking?
Hospitals are using generative AI beyond note-taking, although most of those applications remain earlier and less reliable.
Doctors already use it to summarize charts, draft discharge instructions, prepare care plans, translate information and propose answers to patient messages. Hospitals are also testing it for coding, appeal letters, clinical search and discharge paperwork.
Patient-message drafting has spread particularly quickly. Fifty-one percent of the large systems in the JAMIA survey had deployed in-basket automation in at least part of the organization.
The results have been mixed. In one controlled study involving 122 physicians, AI-generated drafts produced longer messages but did not reduce the time doctors spent replying. Reading and checking the suggested answer could consume the time saved by writing it.
Patient-facing conversational AI is moving more slowly. Only 5% of surveyed systems had fully deployed AI companions, with another 17% using them in limited areas. AI care-navigation and triage tools were almost entirely in development or pilot stages.
Hospitals are right to move more slowly here. A flawed note remains visible to the doctor before it enters the record. A chatbot giving a worried patient the wrong advice creates a more immediate risk.
Hospitals currently prefer generative AI one step behind the professional. It prepares, summarizes or suggests, and an employee approves the final output.

This chart, featured in our healthcare AI market deck, compares the main business model options for ambient AI companies
Is AI already running hospital billing and operations?
AI is already deeply involved in hospital billing, scheduling and operational work.
The latest national hospital data show where adoption is accelerating fastest. Among hospitals using predictive AI, billing use jumped from 36% to 61% in one year. Scheduling increased from 51% to 67%.
Those changes were much larger than the two-point rise in AI used for treatment recommendations. Hospitals are moving fastest where errors can be checked and the financial return is easy to measure.
Large systems are also using AI for medical coding, prior authorization, staffing forecasts, claims review and operating-room planning. In the JAMIA survey, 45% had deployed medical-coding AI, while 33% had deployed tools for operating-room utilization.
A hospital processing millions of claims does not need a miraculous result. Cutting a few minutes from each review, catching missing information or improving the order of work can save a meaningful amount of money.
AI also enters hospitals through existing software. The federal survey found that 80% of hospitals using predictive AI obtained at least one model from their electronic-record provider. Fifty-two percent used third-party systems, and half reported some internally developed AI.
That makes the spread less visible. A hospital employee may begin using AI after an ordinary software update rather than through a large standalone project.
Administrative AI is currently one of the most important parts of hospital adoption. It receives less public attention than diagnosis, but hospitals can deploy it faster, measure it more clearly and use it across much larger volumes of work.
Has hospital AI actually improved patient outcomes?
Hospital AI has improved patient outcomes in several strong deployments, but the best evidence remains concentrated in narrow, time-sensitive problems.
Stroke care in England offers the clearest large-scale case. A national evaluation used data from 452,952 stroke patients, including more than 71,000 treated at 26 evaluation hospitals after AI was introduced.
At primary stroke centers using the imaging system, thrombectomy rates doubled from 2.3% to 4.6%. The average time needed to transfer suitable patients to a specialist center fell by 64 minutes. Patients whose scans were reviewed with AI were also more likely to receive clot-removing treatment and achieve a favorable outcome at discharge.
Sepsis provides two further examples. TREWS was associated with a 3.3-point absolute mortality reduction when clinicians responded quickly. COMPOSER was associated with a 1.9-point reduction and better compliance with treatment guidelines.
The strong outcome studies share a blunt pattern. The AI identifies a specific urgent problem, the hospital already has an effective treatment, and faster action can change the result.
Many other hospital AI studies measure time saved, note completion, coding volume or employee satisfaction. Those outcomes still have value, although they give us weaker evidence about whether patients recover faster or live longer.
| AI deployment | Scale examined | Main measured result | What we can reasonably conclude |
|---|---|---|---|
| England stroke-imaging AI | 452,952-patient national dataset | Thrombectomy rose from 2.3% to 4.6%; transfers became 64 minutes faster | AI can speed access to proven stroke treatment |
| TREWS sepsis alerts | Five hospitals | 3.3-point lower adjusted mortality with fast confirmation | Early warnings can improve survival when staff act |
| COMPOSER sepsis model | 6,217 patients in two emergency departments | 1.9-point lower mortality and better treatment compliance | A well-integrated model can improve real care |
| Providence ambient scribe | 1,547 active clinicians | Note time fell by about one minute per appointment | Strong workflow evidence, without direct proof of better health |
| AI-drafted patient messages | 122 physicians | Longer replies but no faster response | Fluent text does not automatically create useful efficiency |

This chart, featured in our healthcare AI market deck, illustrates how revenue is distributed across customer segments in the healthcare AI market
Do hospitals know whether their AI stays safe after launch?
Many hospitals evaluate AI before and after deployment, but their monitoring still has large holes.
The federal health IT analysis found that 82% of AI-using hospitals evaluated predictive models for accuracy. Seventy-four percent assessed bias, and 79% reported some form of monitoring after implementation.
The headline percentages look reassuring. The survey wording, however, allowed hospitals to answer yes when they performed the check on only some models.
Knowledge gaps were also common. Fifteen percent of hospitals did not know whether accuracy testing had occurred. Twenty-one percent could not say whether anyone had checked for bias, and 18% were unsure about monitoring after launch.
Independent hospitals reported much weaker oversight. Only 41% evaluated accuracy, 31% evaluated bias and 38% monitored performance after deployment. Their health-system counterparts reached 76%, 62% and 62%.
Ongoing checks are essential because hospital data change. A model may face a new scanner, different patient population, altered laboratory process or revised clinical guideline. Performance at the hospital where it was developed does not guarantee the same performance elsewhere.
The FDA is now focusing more attention on real-world monitoring for AI-enabled devices. That reflects a basic problem with medical AI: approval or validation captures one period, while hospitals may use the product for years.
Current governance is much stronger than it was a few years ago. It still falls short of a world where every hospital can name the owner, performance threshold and shutdown rule for every algorithm it runs.
If you want more recent data on this point, please see our latest healthcare AI market report.
Why are rural and independent hospitals falling behind?
Rural and independent hospitals are falling behind because AI requires money, technical staff and shared infrastructure long after the software has been purchased.
An independent hospital has to evaluate the vendor, connect the system to its records, train employees, monitor errors and create its own governance process. A large hospital network can perform much of that work once and spread the cost across dozens of facilities.
The resulting gap is enormous. Predictive AI use reached 86% among hospitals in multihospital systems and 37% among independent hospitals. Urban hospitals reached 81%, compared with 56% in rural areas.
A newer study of 2,720 hospitals found a similar split using broader definitions. Sixty-eight percent had adopted at least one clinical AI function, and 60.7% had adopted an operational one.
The researchers also identified what they called “AI deserts.” Among hospitals without AI, 12.1% of clinical non-adopters and 13.2% of operational non-adopters were more than 50 miles from the nearest adopting hospital.
Electronic-record vendors can either narrow or widen this divide. Ninety percent of hospitals using the leading EHR provider reported predictive AI use, compared with 50% among hospitals using other vendors.
For many smaller hospitals, the easiest path to AI will come through shared networks and tools already built into their records. Expecting each rural hospital to build its own data and governance team would leave the gap in place.
Hospital AI is widespread today, but its benefits are reaching well-resourced health systems first.

This chart, featured in our healthcare AI market deck, shows how symptom checker app technology has evolved over time
Is AI replacing doctors and hospital staff?
AI is replacing parts of hospital jobs much faster than it is replacing entire jobs.
A scribe drafts the note, while the doctor checks and signs it. Imaging software marks a possible abnormality, while the radiologist reviews the complete scan. A coding tool suggests a code, while an employee handles uncertain cases and appeals.
The goals reported by hospital leaders support this view. In the survey of 43 health systems, 72% ranked reducing caregiver burden and improving satisfaction among their top two AI priorities. Patient safety and workflow efficiency followed. Financial margin and market share appeared much less often.
Hospitals currently face shortages of nurses, doctors, technicians and administrative staff. Their immediate use for AI is to stretch limited workers across more tasks.
That does not guarantee every role is safe. Coding, transcription, scheduling and basic claims work contain many repetitive steps that software can absorb. Employers may gradually hire fewer people, combine roles or move employees toward exception handling.
The AMA’s latest survey also found that 70% of physicians saw opportunities to automate tasks that contribute to burnout. At the same time, 88% expressed at least some concern about losing professional skills.
The tension is real. A clinician may welcome the removal of repetitive paperwork while worrying about becoming too dependent on automated suggestions.
The near-term unit of automation is the task. Hospitals are removing minutes of work from many jobs rather than removing the people who hold them.
What part of hospital AI is still hype?
The hype comes from describing narrow, supervised hospital tools as if autonomous medical intelligence had already arrived.
One hospital may operate a billing model, a stroke-imaging tool and an experimental chatbot. Calling it an “AI hospital” hides the fact that each system handles a small, separate job.
Adoption figures can create the same confusion. Ninety percent of large systems had imaging AI somewhere, but only 40% had deployed it fully. Every surveyed system was working on ambient notes, while full deployment reached 14%.
Hospitals also deploy products before they know whether the products work well. Only 19% of surveyed health systems rated diagnostic AI as highly successful, despite widespread imaging adoption. Clinical risk stratification reached 38%.
Generative AI adds another layer of exaggeration because fluent writing looks more intelligent than it is. A polished note or patient message may still contain a subtle factual error that requires careful checking.
We should also be cautious with studies from leading academic centers. These hospitals have experienced data teams, strong technology budgets and close relationships with vendors. Their results may take longer to reproduce in a small community hospital.
Even the strongest AI-scribe studies generally find modest time savings per appointment. Those minutes can add up, but they fall well below the promise of eliminating clinical paperwork.
Hospital AI itself is real. Claims of autonomous diagnosis, effortless cost savings and rapid replacement of medical staff run far ahead of the evidence.
If you want more recent data on this point, please see our latest healthcare AI market report.

In our healthcare AI market deck, we identify pain points entrepreneurs should prioritize
Are hospitals actually using AI today?
Yes, hospitals are unquestionably using AI today, and it has already become part of routine care and operations.
The broadest national evidence shows predictive AI inside most American acute-care hospitals. Large systems have moved imaging, sepsis detection, documentation and coding into production. Physicians report using AI at more than twice the rate seen three years earlier.
The most established tools currently review scans, draft notes, calculate risk, prepare codes, manage claims and organize work. Hospitals use them repeatedly on real patients and real transactions.
A smaller group of deployments has also produced better patient outcomes. England’s stroke rollout shortened transfers and increased access to thrombectomy. Sepsis systems at Johns Hopkins and UC San Diego were associated with lower mortality when tied to fast clinical action.
The popular picture is still ahead of reality. AI rarely makes the final diagnosis, patient-facing agents remain limited and many tools have reached only part of the workforce. Monitoring is uneven, smaller hospitals lag badly and measurable benefits vary from one product to another.
The judgment is straightforward: hospitals are genuinely using AI at scale, but mainly as supervised, specialized infrastructure.
AI already influences which scan gets read first, which patient receives extra attention, how a note is written and how a claim is processed. Humans continue to own the consequential decisions.
That may sound less dramatic than an AI doctor. It is still a major change in how hospitals work.
OUR METHODOLOGY
We treated hospital AI use as a series of measurable questions rather than a single adoption figure. Buying a tool, testing it, deploying it widely, improving care and replacing work are different stages, so we assessed them separately.
We counted AI as genuinely deployed when it touched real patients, records, scans, claims or hospital operations. We then looked at scale, the level of human review and whether the hospital had measured an operational or clinical result.
We used national hospital surveys to establish breadth, health-system studies to separate pilots from full deployment, regulatory data to map the available clinical products, and peer-reviewed evaluations to test whether individual systems improved workflow or patient outcomes.
We gave the most weight to nationwide datasets, large multicenter studies and observed deployments. Vendor announcements and isolated demonstrations were useful only when they added specific, checkable information.
Adoption and success were not treated as synonyms. A hospital could have an imaging model in production without rating it highly, and a widely available scribe could still be used by only a minority of eligible clinicians.
Key sources included the ASTP/ONC analysis of predictive AI adoption and governance, the full federal predictive AI report, the JAMIA survey of 43 health systems, the American Medical Association’s physician AI research, the FDA list of AI-enabled medical devices, and NHS England’s clinical AI material.
For outcome evidence, we relied particularly on the TREWS sepsis study, the COMPOSER deployment study, and the independent evaluation of Epic’s sepsis model. Comparing successful and weak deployments helped separate the value of an algorithm from the value of the clinical process around it.

This chart, featured in our healthcare AI market deck, illustrates how revenue is distributed geographically across Europe, Asia, North America, Africa, and South America in the healthcare AI market
Related blog posts
- Are doctors actually using AI today?
- Who is setting the standard for healthcare AI agents?
- Who is leading AI-powered clinical documentation?
Who is the author of this content?
NEW MARKET PITCH TEAM
We track new markets so founders and investors can move fasterWe build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.